{"id":"NCT04592419","sponsor":"Kodiak Sciences Inc","briefTitle":"A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)","officialTitle":"A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Visual Impairment Due to Treatment-naïve Macular Edema Secondary to Retinal Vein Occlusion (RVO)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-25","primaryCompletion":"2022-06-10","completion":"2023-01-19","firstPosted":"2020-10-19","resultsPosted":"2024-06-06","lastUpdate":"2024-06-26"},"enrollment":568,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Macular Edema","Retinal Vein Occlusion"],"interventions":[{"type":"DRUG","name":"KSI-301","otherNames":[]},{"type":"DRUG","name":"Aflibercept","otherNames":["Eylea"]},{"type":"OTHER","name":"Sham Procedure","otherNames":[]}],"arms":[{"label":"KSI-301 (Arm A)","type":"EXPERIMENTAL"},{"label":"Aflibercept (Arm B)","type":"ACTIVE_COMPARATOR"}],"summary":"This Phase 3 study will evaluate the efficacy, durability, and safety of KSI-301 compared to aflibercept, in participants with macular edema due to treatment-naïve branch (BRVO) or central retinal vein occlusion (CRVO).","primaryOutcome":{"measure":"Mean Change in Best Corrected Visual Acuity (BCVA) From Day 1 to Week 24 in BRVO Participants.","timeFrame":"Day 1 to Week 24","effectByArm":[{"arm":"KSI-301 (Arm A)","deltaMin":14.2,"sd":0.81},{"arm":"Aflibercept (Arm B)","deltaMin":15.6,"sd":0.79}],"pValues":[{"comp":"OG000 vs OG001","p":".0004"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":141,"countries":["United States","Czechia","France","Germany","Hungary","Israel","Italy","Latvia","Poland","Puerto Rico","Slovakia","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":284},"commonTop":["COVID-19","Hypertension","Conjunctival haemorrhage - Study eye"]}}